Under a theory proposed by Chinese scientists that lifeless biomaterials made of calcium and phosphor can induce bone formation, an artificial bone was induced to form at the Chinese National Biomaterials Engineering and Technology Center.  The material, with a function to form bones, rather than adding bone growth factors or cultured live bone tissues or cells, has been used in clinical trials, demonstrating fine therapeutic effects.

The success of the new technology raises the research level of China?痵 biomaterial science, and gathers together a great number of scientists in the field, which spurs up the development of the industry, said GU Weizhong, chief scientist for biomaterials under the national 973 program. He added that Chinese scientists discovered and proposed the theory that lifeless biomaterials made of calcium and phosphor can induce bone formation, and established an original theory on biomaterials based bone forming, which is of great international influence. Chinese scientists also proposed the theory that a biomaterial that maintains the core protein pattern unchanged in blood clotting system is clotting resistant, which opens up a new clue to address anti-clotting issues in preparing materials for repairing cardiovascular system.  Chinese researchers have worked out nanometer based phosphorite hydroxide, a structure like collagen. At the same time, they developed internationally advanced genetic target control and release carriers that can be used in caner treatment.  The biomaterial project also rolled out a new blood sorbent for treating high blood fat and rheumatoid arthritis, whose patented technology was transferred to overseas buyers.